| Donna J Hogue, DO | |
|
900 Centennial Blvd, Suite K, Voorhees, NJ 08043-4637 | |
| (856) 325-6789 | |
| (856) 325-6545 |
| Full Name | Donna J Hogue |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 33 Years |
| Location | 900 Centennial Blvd, Voorhees, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215939061 | NPI | - | NPPES |
| 3K6158 | Other | NJ | HEALTHNET, INC |
| 1255763 | Other | NJ | AETNA |
| 016496 | Medicaid | NJ | |
| 001007585 | Other | NJ | AMERICHOICE |
| 2308332000 | Other | NJ | AMERIHEALTH/KEYSTONE/IBC |
| 7311605 | Medicaid | NJ | |
| P3601408 | Other | NJ | OXFORD |
| 1632777 | Other | NJ | AMERIHEALTH PPO |
| 1822711 | Other | NJ | UNITED HEALTHCARE |
| 3703636 | Other | NJ | CIGNA |
| 42422 | Other | NJ | UNIVERSITY HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 05007730-L (Pennsylvania) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 25MA07764500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmc Department Of Medicine Group Pa | 2163335878 | 329 |
News Archive
Antibiotics revolutionized the care of infections. Vaccines turned deadly childhood diseases into distant memories. Americans lived longer, healthier lives than their parents.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
The Latino population is the nation's largest minority group at an estimated 47 million in 2008 and is predicted to make up 30% of the US population by 2050. At the same time, chronic diseases among Latinos are on the rise and require long-range strategies to prevent and clinically manage. Understanding the healthcare of this fastest growing population is critical to the healthcare debate and reform initiatives.
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.
Amid the coronavirus disease (COVID-19) pandemic, many countries across the globe have imposed lockdowns in an attempt to reduce the spread of the virus. Still, some countries have not opted for lockdowns, and community quarantines, and still are doing well. Hong Kong, for one, appears to have averted a major COVID-19 outbreak despite not imposing lockdown.
› Verified 2 days ago
| Entity Name | Cmc Department Of Medicine Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679605554 PECOS PAC ID: 2163335878 Enrollment ID: O20050203000280 |
News Archive
Antibiotics revolutionized the care of infections. Vaccines turned deadly childhood diseases into distant memories. Americans lived longer, healthier lives than their parents.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
The Latino population is the nation's largest minority group at an estimated 47 million in 2008 and is predicted to make up 30% of the US population by 2050. At the same time, chronic diseases among Latinos are on the rise and require long-range strategies to prevent and clinically manage. Understanding the healthcare of this fastest growing population is critical to the healthcare debate and reform initiatives.
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.
Amid the coronavirus disease (COVID-19) pandemic, many countries across the globe have imposed lockdowns in an attempt to reduce the spread of the virus. Still, some countries have not opted for lockdowns, and community quarantines, and still are doing well. Hong Kong, for one, appears to have averted a major COVID-19 outbreak despite not imposing lockdown.
› Verified 2 days ago
| Entity Name | Cmc Department Of Medicine Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265565667 PECOS PAC ID: 2163335878 Enrollment ID: O20050504000294 |
News Archive
Antibiotics revolutionized the care of infections. Vaccines turned deadly childhood diseases into distant memories. Americans lived longer, healthier lives than their parents.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
The Latino population is the nation's largest minority group at an estimated 47 million in 2008 and is predicted to make up 30% of the US population by 2050. At the same time, chronic diseases among Latinos are on the rise and require long-range strategies to prevent and clinically manage. Understanding the healthcare of this fastest growing population is critical to the healthcare debate and reform initiatives.
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.
Amid the coronavirus disease (COVID-19) pandemic, many countries across the globe have imposed lockdowns in an attempt to reduce the spread of the virus. Still, some countries have not opted for lockdowns, and community quarantines, and still are doing well. Hong Kong, for one, appears to have averted a major COVID-19 outbreak despite not imposing lockdown.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donna J Hogue, DO 900 Centennial Blvd, Suite K, Voorhees, NJ 08043-4637 Ph: (856) 325-6789 | Donna J Hogue, DO 900 Centennial Blvd, Suite K, Voorhees, NJ 08043-4637 Ph: (856) 325-6789 |
News Archive
Antibiotics revolutionized the care of infections. Vaccines turned deadly childhood diseases into distant memories. Americans lived longer, healthier lives than their parents.
Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.
The Latino population is the nation's largest minority group at an estimated 47 million in 2008 and is predicted to make up 30% of the US population by 2050. At the same time, chronic diseases among Latinos are on the rise and require long-range strategies to prevent and clinically manage. Understanding the healthcare of this fastest growing population is critical to the healthcare debate and reform initiatives.
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.
Amid the coronavirus disease (COVID-19) pandemic, many countries across the globe have imposed lockdowns in an attempt to reduce the spread of the virus. Still, some countries have not opted for lockdowns, and community quarantines, and still are doing well. Hong Kong, for one, appears to have averted a major COVID-19 outbreak despite not imposing lockdown.
› Verified 2 days ago
Kumar Rajagopalan, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 900 Centennial Blvd Ste M, Voorhees, NJ 08043 Phone: 856-325-6750 Fax: 856-325-6777 | |
Amy M Evangelisto, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2301 E. Evesham Road, Bldg 800, Suite 115, Voorhees, NJ 08043 Phone: 856-424-5005 Fax: 856-424-4716 | |
Stephen M Akers, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 900 Centennial Blvd, Suite K, Voorhees, NJ 08043 Phone: 856-325-6789 | |
Jason Palermo, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2309 E Evesham Rd, Suites 201 & 202, Voorhees, NJ 08043 Phone: 856-325-5400 Fax: 856-325-5416 | |
Dr. Robert Charles Baker, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 75 Wynnewood Dr, Voorhees, NJ 08043 Phone: 609-352-2012 Fax: 856-489-1420 | |
Dr. Eduardo Francisco Enriquez, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Brendenwood Dr, Voorhees, NJ 08043 Phone: 856-874-0202 Fax: 856-874-0220 | |
Arielle S. Silver, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2301 E. Evesham Road, Bldg 800, Suite 115, Voorhees, NJ 08043 Phone: 856-424-5005 Fax: 856-424-4716 |